Clinical Trial Update: Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Usnoflast for treatment efficacy in Amyotrophic lateral sclerosis, with status listed as active but not currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Usnoflast

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: ACTIVE_NOT_RECRUITING